These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5692409)

  • 21. [Single or double dose of vaccine needed for the eradication of measles in Spain?].
    Vitoria Miñana I; Morales Suárez-Varela M; Cotanda Gutiérrez P; Asensi Botet F
    An Esp Pediatr; 1993 Feb; 38(2):130-4. PubMed ID: 8439098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of clinical reactions and the fluctuation of antibody levels after measles vaccination. (1) Clinical reactions and serum antibody values after vaccination with raw vaccine only].
    Kubota K
    Nihon Shonika Gakkai Zasshi; 1967 Dec; 71(12):1478-83. PubMed ID: 4175590
    [No Abstract]   [Full Text] [Related]  

  • 24. [Field study on measles vaccination in Basle].
    Just M; Ritzel G
    Schweiz Med Wochenschr; 1966 May; 96(18):583-7. PubMed ID: 5992587
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunization against measles in the GDR and current results of the program to combat measles].
    Starke G; Gerike E; Hlinak P
    Z Gesamte Hyg; 1980; 26(12):881-5. PubMed ID: 7234002
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles antibody response in vaccinated children.
    Evliyaoğlu N; Altintaş D; Kiliç NB; Alhan SE; Onenli N; Güneşer S; Bahçebaşi T
    Turk J Pediatr; 1996; 38(3):315-21. PubMed ID: 8827900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and immunoserological studies of measles vaccine inoculation].
    Ichinomiya K
    Nihon Shonika Gakkai Zasshi; 1968 Jul; 72(7):875-86. PubMed ID: 4178508
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 31. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

  • 33. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G; Hoon HB; Ong A; Chua LT; Kai CS; Tai GK
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles vaccine efficacy: influence of age at vaccination vs. duration of time since vaccination.
    Shelton JD; Jacobson JE; Orenstein WA; Schulz KF; Donnell HD
    Pediatrics; 1978 Dec; 62(6):961-4. PubMed ID: 733424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on clinical reactions after inoculation of measles vaccine and transition of antibody values. 2. Clinical reactions with combination of inactivated raw vaccine and blood antibody value].
    Kubota K
    Nihon Shonika Gakkai Zasshi; 1968 Jan; 72(1):16-20. PubMed ID: 5691552
    [No Abstract]   [Full Text] [Related]  

  • 37. [Measles vaccination].
    Enders G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 39. Measles immunity and immunization in developing countries of Africa: a review.
    Abdurrahman MB; Taqi AM
    Afr J Med Med Sci; 1981; 10(1-2):57-62. PubMed ID: 6287828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.